Latest filing published 12 May 2008 for Marina Biotech, Inc., €7,366.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Gerald T. Stanewick: trading record in brief
This profile gathers the share dealings of Gerald T. Stanewick in Marina Biotech, Inc. We count 14 filings; the first trade dates from 5 April 2006 and the latest from 12 May 2008.
The open-market side counts 9 purchases for €95k alongside 2 sales for €85k. On balance, insiders were net buyers of €9,352. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. 2008 to date brings 3 purchases and no sales.
The median purchase comes to €7,366.
The newest entry dates from 12 May 2008: an open-market purchase of €7,366, in Marina Biotech, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gerald T. Stanewick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.14Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-08-029281:0Canonical exit: 10 Aug 2008 (T+90)
- 900 shares@ US$2.39Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-08-019257:0Canonical exit: 17 Jun 2008 (T+90)
- 4,100 shares@ US$2.40Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-08-019257:1Canonical exit: 17 Jun 2008 (T+90)
- 4,200 shares@ US$14.21Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-053140:0
- 2,000 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-037372:0
- 2,000 shares@ US$10.73Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-07-016878:0Canonical exit: 6 Jun 2007 (T+90)
- 777 shares@ US$15.80Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-064249:0Canonical exit: 8 Mar 2007 (T+90)
- 433 shares@ US$15.67Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-064249:1Canonical exit: 11 Mar 2007 (T+90)
- 290 shares@ US$15.67Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-064249:2Canonical exit: 11 Mar 2007 (T+90)
- 700 shares@ US$15.67Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-064249:3Canonical exit: 11 Mar 2007 (T+90)
- 1,300 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-056846:0
- 3,000 shares@ US$15.75Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-054347:0Canonical exit: 4 Jan 2007 (T+90)
- 2,000 shares0Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-036752:0
- 3,000 shares@ US$17.25Nastech Pharmaceutical Company Inc Common StockSEC:0001209191-06-023100:0
14 of 14 declarations